News | June 09, 2024
Ecolab and Repligen launch DurA Cycle affinity resin for biologic manufacturing
DurA Cycle is designed for large-scale commercial manufacturing of monoclonal antibodies,
DurA Cycle is designed for large-scale commercial manufacturing of monoclonal antibodies,
New data on the secondary endpoint shows up to 52.3% of adults with fibrosis stages F1, F2 and F3 had improvement in fibrosis due to MASH
Dr. Reddy's Laboratories gets Form 483 from USFDA with 4 observations for API facility
Shelter Pharma Limited secured an order from Berlin International Medical Co D3Cure 50 ml x 30000 pcs
Canagliflozin and Metformin Hydrochloride Tablets are used to treat type 2 diabetes mellitus
Merck has opened its newly expanded Life Science distribution center in Schnelldorf, Germany
PICCOLO trial met its primary endpoint of objective response rate (ORR)
Updated analysis from Memorial Sloan Kettering Cancer Center presented at ASCO 2024 has expanded to 42 patients with clinical complete response
Recommendation based on FLAURA2 results which showed Tagrisso plus chemotherapy extended median progression-free survival by nearly 9 months
Dual immunotherapy combination of Opdivo plus Yervoy demonstrated improved survival benefit compared to lenvatinib or sorafenib in this patient population
Subscribe To Our Newsletter & Stay Updated
